These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 22595458)
21. Clustered DNA methylation changes in polycomb target genes in early-stage liver cancer. Chen YL; Ko CJ; Lin PY; Chuang WL; Hsu CC; Chu PY; Pai MY; Chang CC; Kuo MH; Chu YR; Tung CH; Huang TH; Leu YW; Hsiao SH Biochem Biophys Res Commun; 2012 Aug; 425(2):290-6. PubMed ID: 22842566 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
23. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693 [TBL] [Abstract][Full Text] [Related]
24. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer. Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877 [TBL] [Abstract][Full Text] [Related]
25. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
26. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines. Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245 [TBL] [Abstract][Full Text] [Related]
27. Reduced BMP6 expression by DNA methylation contributes to EMT and drug resistance in breast cancer cells. Liu G; Liu YJ; Lian WJ; Zhao ZW; Yi T; Zhou HY Oncol Rep; 2014 Aug; 32(2):581-8. PubMed ID: 24890613 [TBL] [Abstract][Full Text] [Related]
28. Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. Hummon AB; Pitt JJ; Camps J; Emons G; Skube SB; Huppi K; Jones TL; Beissbarth T; Kramer F; Grade M; Difilippantonio MJ; Ried T; Caplen NJ Mol Cancer; 2012 Jan; 11():1. PubMed ID: 22216762 [TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of CASP8AP2 gene methylation in childhood acute lymphoblastic leukemia]. Liu FF; Liu X; Wang KL; Li WJ; Deng GR; Gao C; Zhao XX; Wu MY; Cui L; Li ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):6-11. PubMed ID: 25687037 [TBL] [Abstract][Full Text] [Related]
30. The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Dansranjavin T; Krehl S; Mueller T; Mueller LP; Schmoll HJ; Dammann RH Cell Cycle; 2009 Mar; 8(6):916-24. PubMed ID: 19221495 [TBL] [Abstract][Full Text] [Related]
31. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734 [TBL] [Abstract][Full Text] [Related]
32. [Aberrant DNA methylation and drug resistance of tumor cells]. Xinxin S; Yujie S Yi Chuan; 2014 May; 36(5):411-9. PubMed ID: 24846990 [TBL] [Abstract][Full Text] [Related]
33. Clustering of Cancer Cell Lines Using A Promoter- Targeted Liquid Hybridization Capture-Based Bisulfite Sequencing Approach. Gao F; Wang J; Ji G; Liu S; Yao Y; Wang T; Wu H; Xia Y; Gong D; Jiang H; Yang H; Zhang X Technol Cancer Res Treat; 2015 Aug; 14(4):383-94. PubMed ID: 26269607 [TBL] [Abstract][Full Text] [Related]
34. [Research Progress on Expression Regulation, Function and Clinical Significance of CASP8AP2 Gene]. Li ZG; Wu MY; Jia HT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):557-61. PubMed ID: 25948224 [TBL] [Abstract][Full Text] [Related]
35. Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells. Chen CC; Lee KD; Pai MY; Chu PY; Hsu CC; Chiu CC; Chen LT; Chang JY; Hsiao SH; Leu YW Cancer Cell Int; 2015; 15():98. PubMed ID: 26464562 [TBL] [Abstract][Full Text] [Related]
36. Exploration of drug-response mechanism by integrating genetics and epigenetics across cancers. Lv W; Zhang M; Zhu J; Zhang M; Ci C; Shang S; Wei Y; Liu H; Li X; Zhang Y Epigenomics; 2018 Jul; 10(7):993-1010. PubMed ID: 29957027 [TBL] [Abstract][Full Text] [Related]
37. CRISPRi screening identifies CASP8AP2 as an essential viability factor in lung cancer controlling tumor cell death via the AP-1 pathway. Myacheva K; Walsh A; Riester M; Pelos G; Carl J; Diederichs S Cancer Lett; 2023 Jan; 552():215958. PubMed ID: 36252816 [TBL] [Abstract][Full Text] [Related]
38. Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Emran AA; Marzese DM; Menon DR; Hammerlindl H; Ahmed F; Richtig E; Duijf P; Hoon DS; Schaider H Epigenomics; 2019 May; 11(7):732-737. PubMed ID: 31070054 [No Abstract] [Full Text] [Related]
39. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities. Shah K; Rawal RM Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353 [TBL] [Abstract][Full Text] [Related]
40. Interaction of E2F3a and CASP8AP2 Regulates Histone Expression and Chemosensitivity of Leukemic Cells. Jin FF; Wang CJ; Cui L; Liu FF; Wang KL; Li WJ; Li ZG J Pediatr Hematol Oncol; 2023 Apr; 45(3):e339-e344. PubMed ID: 36162009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]